Neuropix brings disruptive medical technology innovatively connected to digital healthcare solutions for treating major brain diseases, in a new generation of neurotechnology set to change healthcare.

Using clinical neuromodulation, our European CE approved medical devices are wearable, non-surgical applications for treating brain disorders including depression (the world-leading disease burden by 2030, WHO), migraine and epilepsy. Considering these disorders, there are already over 1.6 and 4 million sufferers that can benefit in Hong Kong and Taiwan, respectively.

With novel bioelectrical medicines, our devices connect wirelessly to the patient’s smart device for medical analytics, giving better support and improving medical treatment decisions by physicians. The portable medical device system provides a powerful platform for up-to-date analysis of health data and treatment routines, towards truly improving healthcare.

Supported with >10 years medical research, there is now tremendous potential across Asia. Neuropix (Cyberport based company) with our world experts are leading the way, using the medical treatment in cases in major hospitals in Hong Kong & Taiwan. Neuropix is also set to lead the expansion to new treatment pipelines for aging-diseases, including use for Alzheimer’s and Parkinson’s disease, for the very vulnerable elderly population that will reach 400 million in China alone by 2040.